← ANALYST RATINGS · TIPRANKS
UnitedHealth (UNH): analyst forecast and price target
Analyst consensus
Strong Buy10 Buy2 Hold0 Sell
Ratings of 12 analysts in the last 3 months · top analysts only12-month forecast
Based on 12 price targets given in the last 3 months, the average target is $500, the highest $529, the lowest $472. The average is +24.5% from the last price of $401.
Analyst ratings 27
| Analyst | Firm | Price target | Rating | Upside | Action | Date | Move vs SPY | |
|---|---|---|---|---|---|---|---|---|
| Lisa Gill★★★★★★★★★★#1237 · hits 58% · avg +9.0% | J.P. Morgan | $516 → $524+1.6% | Buy | +30.5% | Assigned | 16.10.26on TipRanks 07:40 | −0.2% | ↗ |
| Lance Wilkes★★★★★★★★★★#1628 · hits 63% · avg +11.3% | Bernstein | $512 → $500−2.3% | Buy | +24.6% | Reiterated | 16.10.26on TipRanks 06:25 | −0.2% | ↗ |
| Parker Snure★★★★★★★★★★#8410 · hits 67% · avg +1.7% | Raymond James | $475 → $450−5.3% | Buy | +12.1% | Reiterated | 15.10.26on TipRanks 09:30 | +2.5%next day −0.2% | ↗ |
| Ryan Langston★★★★★★★★★★#9454 · hits 47% · avg −0.6% | TD Cowen | $402 | Hold | +0.1% | Reiterated | 15.10.26on TipRanks 08:50 | +2.5%next day −0.2% | ↗ |
| AI xAi Medical - Healthcare PlansxAI Grok-4 | TipRanks - xAI | $417 → $408−2.2% | Hold | +1.6% | Reiterated | 14.10.26on TipRanks 10:05 | — | |
| AI DeepSeek Medical - Healthcare PlansDeepSeek V3.2-Speciale | TipRanks - DeepSeek | $417 → $391−6.2% | Hold | −2.6% | Reiterated | 14.10.26on TipRanks 10:05 | — | |
| AI OpenAI Medical - Healthcare PlansOpenAI 5.2 | TipRanks - OpenAI | $417 → $416−0.2% | Buy | +3.6% | Upgrade | 14.10.26on TipRanks 10:05 | — | |
| AI Anthropic Medical - Healthcare PlansAnthropic Opus-4.6 | TipRanks - Anthropic | $385 → $412+7.0% | Hold | +2.6% | Reiterated | 14.10.26on TipRanks 10:05 | — | |
| AI Google Medical - Healthcare PlansGemini 3.1Pro | TipRanks - Google | $423 → $427+0.9% | Buy | +6.4% | Reiterated | 14.10.26on TipRanks 10:05 | — | |
| AI PerPlexity Medical - Healthcare PlansPerPlexity SonarPro | TipRanks - PerPlexity | $422 → $400−5.2% | Hold | −0.4% | Downgrade | 14.10.26on TipRanks 10:05 | — | |
| Whit Mayo★★★★★★★★★★#3228 · hits 49% · avg +3.6% | Leerink Partners | $472 | Buy | +17.6% | Assigned | 14.10.26on TipRanks 09:12 | +5.8%next day +2.5% | ↗ |
| Michael Ha★★★★★★★★★★#10152 · hits 42% · avg −2.4% | Robert W. Baird | $453 → $427−5.7% | Hold | +6.4% | Reiterated | 14.10.26on TipRanks 07:30 | +5.8%next day +2.5% | ↗ |
| Jessica Tassan★★★★★★★★★★#11189 · hits 43% · avg −3.3% | Piper Sandler | $502 → $504+0.4% | Buy | +25.6% | Reiterated | 14.10.26on TipRanks 06:55 | +5.8%next day +2.5% | ↗ |
| Erin Wright★★★★★★★★★★#354 · hits 64% · avg +15.1% | Morgan Stanley | $468 → $529+13.0% | Buy | +31.8% | Reiterated | 14.10.26on TipRanks 06:30 | +5.8%next day +2.5% | ↗ |
| Andrew Mok CFA★★★★★★★★★★#11840 · hits 51% · avg −4.8% | Barclays | $441 → $440−0.2% | Buy | +9.6% | Reiterated | 14.10.26on TipRanks 05:01 | +5.8%next day +2.5% | ↗ |
| Scott Fidel★★★★★★★★★★#1346 · hits 64% · avg +7.9% | Goldman Sachs | $490 → $506+3.3% | Buy | +26.0% | Reiterated | 13.10.26on TipRanks Oct 14 08:30 | −0.2%next day +5.8% | ↗ |
| Kevin Fischbeck★★★★★★★★★★#8009 · hits 57% · avg +0.1% | Bank of America Securities | $512 | Buy | +27.5% | Reiterated | 13.10.26on TipRanks Oct 14 05:26 | −0.2%next day +5.8% | ↗ |
| Elizabeth Anderson CFA★★★★★★★★★★#2664 · hits 55% · avg +4.4% | Evercore ISI | $480 | Buy | +19.6% | Reiterated | 13.10.26on TipRanks 10:05 | −0.2%next day +5.8% | ↗ |
| A.J. Rice★★★★★★★★★★#690 · hits 61% · avg +9.8% | UBS | $490 | Buy | +22.1% | Reiterated | 12.10.26on TipRanks Oct 13 01:16 | −0.1%next day −0.2% | ↗ |
| Hans Engel★★★★★★★★★★#1835 · hits 58% · avg +11.1% | Erste Group | — | Hold | — | Reiterated | 08.10.26on TipRanks 06:55 | −0.9%next day +1.7% · 5 days +9.9% | ↗ |
| Ben Hendrix★★★★★★★★★★#1571 · hits 53% · avg +7.2% | RBC Capital | $478 | Buy | +19.1% | Reiterated | 07.10.26on TipRanks Oct 8 21:45 | +0.1%next day −0.9% · 5 days +6.2% | ↗ |
| Stephen Baxter★★★★★★★★★★#3289 · hits 50% · avg +3.9% | Wells Fargo | $526 | Buy | +31.0% | Reiterated | 15.09.26on TipRanks 07:25 | −1.5%next day +0.3% · 5 days −3.2% | ↗ |
| George Hill★★★★★★★★★★#1126 · hits 54% · avg +9.0% | Deutsche Bank | — | Hold | — | Reiterated | 03.08.26on TipRanks 09:55 | −1.2%next day −3.7% · 5 days −3.6% | ↗ |
| Ann Hynes★★★★★★★★★★#1003 · hits 59% · avg +8.1% | Mizuho Securities | $470 → $493+4.9% | Buy | +22.8% | Reiterated | 21.07.26on TipRanks Jul 24 05:11 | +2.7%next day −1.0% · 5 days −0.7% | ↗ |
| David Toung★★★★★★★★★★#1098 · hits 63% · avg +9.1% | Argus Research | $400 → $470+17.5% | Buy | +17.1% | Reiterated | 17.07.26on TipRanks Jul 24 05:11 | +1.6%next day −0.9% · 5 days −0.7% | ↗ |
| Michael Wiederhorn★★★★★★★★★★#535 · hits 59% · avg +11.3% | Oppenheimer | $420 → $500+19.0% | Buy | +24.6% | Assigned | 17.07.26on TipRanks Jul 16 08:15 | +1.7%next day +1.6% · 5 days +1.7% | ↗ |
| David S Macdonald★★★★★★★★★★#400 · hits 63% · avg +13.2% | Truist Financial | $480 → $500+4.2% | Buy | +24.6% | Reiterated | 17.07.26on TipRanks Jul 14 07:55 | −1.3%next day −2.0% · 5 days +3.1% | ↗ |
| Matthew Gillmor CFA★★★★★★★★★★#6184 · hits 53% · avg +2.0% | KeyBanc | $400 → $475+18.8% | Buy | +18.3% | Reiterated | 14.07.26on TipRanks 04:41 | −1.3%next day −2.0% · 5 days +3.1% | ↗ |
| Sidharth Sahoo★★★★★★★★★★#9090 · hits 43% · avg −0.9% | HSBC | $300 → $380+26.7% | Hold | −5.3% | Reiterated | 06.07.26on TipRanks 10:35 | −2.6%next day +2.9% · 5 days +2.9% | ↗ |
| John Ransom★★★★★★★★★★#681 · hits 60% · avg +10.2% | Raymond James | $330 → $370+12.1% | Buy | −7.8% | Reiterated | 22.04.26on TipRanks 10:30 | +1.2%next day +0.7% · 5 days +4.8% | ↗ |
| David Windley★★★★★★★★★★#769 · hits 59% · avg +9.3% | Jefferies | $340 → $373+9.7% | Buy | −7.1% | Reiterated | 20.04.26on TipRanks 06:35 | −0.2%next day +7.6% · 5 days +8.7% | ↗ |
| Sarah James★★★★★★★★★★#2265 · hits 55% · avg +5.7% | Cantor Fitzgerald | $440 | Buy | +9.6% | Reiterated | 28.01.26on TipRanks 07:20 | +4.0%next day −0.4% · 5 days −4.8% | ↗ |
| Justin Lake★★★★★★★★★★#1616 · hits 68% · avg +12.7% | Wolfe Research | $363 → $330−9.1% | Buy | −17.8% | Reiterated | 27.10.25on TipRanks Oct 28 08:35 | −0.2%next day +0.2% · 5 days −8.5% | ↗ |
| No ratings for this filter. | ||||||||
The latest rating of each analyst in the last 12 months, as TipRanks lists them. Every rating kept, earlier ones included
Best analysts covering UnitedHealth
TipRanks picks them by their record on this stock; the figures under the name are their record across all their ratings.
Most accurate
Most profitable
How the average price target moved
The average target of all analysts (their ratings of the 3 months before) on each day, the top analysts’ dashed, against the price; the site keeps this record since 1 October 2026. On 01.10.26: target $482 at a price of $367 (+31.2%); now: $483 at $401 (+20.4%).
PriceAverage targetTop analysts’ target
Recommendation trend · top analysts
Strong BuyBuyHoldSell
| Rating | 05.26 | 06.26 | 07.26 | 08.26 | 09.26 | 10.26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 0 | 0 | 0 | 0 | 0 |
| Buy | 28 | 34 | 27 | 22 | 22 | 18 |
| Hold | 2 | 2 | 0 | 2 | 2 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Earnings and sales forecast
Next report: 20.01.27 (Q4 2026, date not confirmed)
Earnings per share
Next quarter’s EPS estimate — $2.27 (from $2.09 to $2.62). Last quarter: $4.69.
Sales
Next quarter’s sales estimate — $112.1B (from $109.1B to $115.4B). Last quarter: $112.7B.
Best top-analyst consensus in the sector · Healthcare
About UnitedHealth
- CEO: Stephen J. Hemsley
- Employees: 390,000
- 1 Health Drive, Eden Prairie, MN, 55344, US
- www.unitedhealthgroup.com
UnitedHealth Group Incorporated (UNH) operates as a comprehensive healthcare enterprise across the United States, structuring its diverse services into four key divisions: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment provides a wide array of health benefit plans and consumer-focused services. These offerings cater to a broad spectrum of clients, including large national corporations, public sector employers, mid-sized and small businesses, and individual consumers. It also delivers specialized health coverage and wellness programs tailored for individuals aged 50 and older, addressing their needs for preventive and acute care, chronic disease management, and other age-specific health issues. This division further encompasses Medicaid plans, children's health insurance, dental benefits, and various hospital and clinical services. Optum Health focuses on delivering direct healthcare solutions and management services. It facilitates access to networks of specialist care providers, offers health management programs, direct care delivery, consumer engagement initiatives, and financial services. Its diverse clientele includes individuals (served directly through care systems), employers, insurance payers, and government organizations. Optum Insight specializes in providing technology, information, and consulting services to the healthcare industry. Its offerings include software and data products, advisory consulting arrangements, and outsourced managed services. Clients span hospital systems, physicians, health plans, governmental bodies, life sciences companies, and other relevant organizations. Finally, Optum Rx handles the company's pharmaceutical care services. This segment manages retail pharmacy networks, provides home prescription delivery, and offers specialty and compounding pharmacy capabilities. Leveraging its purchasing power and clinical expertise, Optum Rx also develops advanced programs related to step therapy,
Data from the stock’s TipRanks forecast page, read 38 min ago. It is read again as soon as a new rating appears and at least every 8 hours. TipRanks ↗